Dr. Bela Kis, MD, PhD

Dr. Kis practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Kis' NPI, 1124257977, was assigned on July 14, 2009. Dr. Kis holds Florida license ME 113401.

Dr. Kis' primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Kis' primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Kis is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Kis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kis practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Kis' primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Kis is licensed in Florida.

CMS data shows 564 Medicare services from Dr. Kis across 18 procedure codes in 2024, for 216 Medicare patients. Medicare paid $40,562 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 216 Medicare patients who saw Dr. Kis in 2024. The largest group is 65 to 74, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 3.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kis' median patient age at 65, with 54% women.

In 2024, Dr. Kis wrote 11 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $511 in total drug cost. In 2020, CMS named 27 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kis for performance year 2024, reported as part of a group. Dr. Kis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 40 papers to Dr. Kis, published from 2011 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Liver Neoplasms, Embolization, Therapeutic and Yttrium Radioisotopes. Dr. Kis has published most often in J Vasc Interv Radiol. Dr. Kis' most frequent co-authors are Junsung Choi, MD, Sarah Elizabeth Hoffe, MD and Jessica M. Frakes.

Dmand AI links Dr. Kis to 1 clinical trial. Conditions studied include Mesothelioma, Malignant and Pleural Neoplasms.

CMS Open Payments shows 231 general payments to Dr. Kis from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 44% of the total. Toshiba America Medical Systems, Inc. paid the most, $9,777.